Physician profile
Jonathan Adkins
NPI 1568563385
$7,354.51
in general payments reported to CMS, 2019-2025
45 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,560 · 2020: $332 · 2021: $904 · 2022: $903 · 2023: $868 · 2024: $1,044 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,654.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,271.89 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $1,090.70 | 2021-2025 | Phasix Mesh |
| Abbvie INC. | $460.93 | 2021-2025 | Strattice Reconstructive Tissue Matrix Bps, Dalvance |
| Kerecis Limited | $338.65 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Boston Scientific Corporation | $323.49 | 2019-2023 | Spyscope Ds, Watchman Flx |
| Ethicon US, LLC | $256.19 | 2020-2025 | Harmonic, Linx Reflux Management System, Echelon; Endopath |
| Medtronic, INC. | $250.81 | 2022-2025 | Symbotex, Signia |
| Allergan, INC. | $213.26 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.56 | 2021-2025 | Gattex |
| Hologic Sales and Service, LLC | $118.89 | 2023-2025 | Coolseal Generator, Localizer, Biozorb |
| Baxter Healthcare | $74.72 | 2019-2022 | |
| Polynovo North America LLC | $73.84 | 2022 | |
| Hydrofera LLC | $53.28 | 2025 | Hydrofera Blue |
| Myriad Genetic Laboratories, INC. | $52.09 | 2025 | Myrisk |
| Smith+Nephew, INC. | $49.64 | 2022-2025 | Collagenase Santyl |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.